PureTech Health plc, a clinical-stage biotherapeutics company dedicated to changing the treatment paradigm for devastating diseases, announced that it will advance LYT-300 (oral allopregnanolone), a clinical therapeutic candidate in development as...
Aster Pharmacy, the retail arm of Aster DM Healthcare and a leading pharmacy chain in the GCC, and Dr. Reddy's laboratories India Ltd, a global pharmaceutical firm headquartered in Hyderabad, India, have signed a memorandum of understanding to...
GlobalData, a data analytics firm, estimated that Moderna's mRNA-3927 is set to generate $278 million in 2028. Moderna recently confirmed that its Phase I/II study of candidate mRNA-3927 is moving forward. It also revealed that data from mRNA-3927...
MSD Pharmaceuticals is likely to participate in a global tender that the Union Health Ministry is likely to float in April to procure HPV vaccine against cervical cancer for immunisation of girls aged 9 to 14. MSD Pharmaceuticals Private Limited...
Aurobindo Pharma said it has received Voluntary Action Indicated (VAI) from the US health regulator for its Telangana-based manufacturing plant. As per the information available on the United States Food and Drug Administration (USFDA) website,...
Torrent Pharmaceuticals said it has forayed into the over-the-counter segment in the country with Shelcal 500, a calcium supplement brand. With its composition of 500mg Calcium and 250 IU of Vitamin D3, Shelcal 500 helps optimise calcium...
Herbalife Nutrition India, a global nutrition firm, has entered the eye health segment with its new product, 'Ocular Defense,' in keeping with its commitment to nutrition and wellness...
Dr Vinod Kotwal, Member Secretary, National Pharmaceuticals Pricing Authority (NPPA) has urged the Indian pharmaceutical companies to register in Integrated Pharmaceutical Database Management System (IPDMS 2.0) for making a robust database...
The pharmaceutical industry is anticipated to register a CAGR of 11.34 per cent until 2028. The sector has undergone a significant transformation owing to the emergence of new technologies, & more efficient manufacturing approaches.
Natco Pharma said it has submitted a new application with the US health regulator for marketing authorisation of the generic version of Olaparib tablets, used in treating certain forms of ovarian, breast, pancreatic and prostate cancers...
, CDSCO.jpg)
